Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma, Head And Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04502888
What this trial is testing

Ph1 Study of SL-172154 Administered Intratumorally in Subjects With Squamous Cell Carcinoma of the Head and Neck or Skin

Who this might be right for
Cutaneous Squamous Cell CarcinomaSquamous Cell Carcinoma of Head and Neck
Shattuck Labs, Inc. 5
Large-scale testing (Phase 3)Ended earlyNCT01627379
What this trial is testing

Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal Squamous Cell Cancer
AIO-Studien-gGmbH 300
Large-scale testing (Phase 3)Looking for participantsNCT06563869
What this trial is testing

Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital with Nanjing Medical University 40
Testing effectiveness (Phase 2)Ended earlyNCT01009346
What this trial is testing

RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHN

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)UnknownNCT02325986
What this trial is testing

Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 46
Not applicableUnknownNCT04984096
What this trial is testing

Anlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer
Shanghai Chest Hospital 50
Testing effectiveness (Phase 2)Study completedNCT03433027
What this trial is testing

BB-401 in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Benitec Biopharma, Inc. 16
Not applicableActive Not RecruitingNCT06401447
What this trial is testing

TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 50
Not applicableLooking for participantsNCT05192655
What this trial is testing

Artificial Intelligence in Functional Imaging for Individualized Treatment of Head and Neck Squamous Cell Carcinoma Patients

Who this might be right for
HNSCC
Charite University, Berlin, Germany 250
Testing effectiveness (Phase 2)UnknownNCT00995358
What this trial is testing

A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
University of Yamanashi 60
Testing effectiveness (Phase 2)Study completedNCT00005035
What this trial is testing

Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Ohio State University Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT04879849
What this trial is testing

TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

Who this might be right for
Carcinoma, Non-Small-Cell LungTriple Negative Breast NeoplasmsSquamous Cell Carcinoma of Head and Neck
Takeda 34
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Early research (Phase 1)Study completedNCT02107235
What this trial is testing

Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer

Who this might be right for
Head and Neck NeoplasmsCarcinoma, Squamous Cell
Traws Pharma, Inc. 2
Large-scale testing (Phase 3)Study completedNCT02644408
What this trial is testing

Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With Chemoradiotherapy

Who this might be right for
Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Henan University of Science and Technology 184
Not applicableLooking for participantsNCT05539638
What this trial is testing

The Role of Circulating Tumour DNA in Head and Neck Cancer

Who this might be right for
Oropharyngeal Squamous Cell CarcinomaHuman Papillomavirus (HPV)
University of Edinburgh 250
Large-scale testing (Phase 3)UnknownNCT00041626
What this trial is testing

Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone

Who this might be right for
Carcinoma, Squamous Cell
Introgen Therapeutics
Testing effectiveness (Phase 2)Study completedNCT03109158
What this trial is testing

NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
NanoCarrier Co., Ltd. 1
Testing effectiveness (Phase 2)Looking for participantsNCT06597565
What this trial is testing

A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 43
Not applicableStudy completedNCT06854107
What this trial is testing

Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma

Who this might be right for
Pathologic Complete Response
Zilong Yuan 225
Next Page